UNCY - Unicycive Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
951
951
0
0
0
Operating Expense
16,430
19,003
8,977
2,020
1,963
Operating Income
-15,479
-18,052
-8,977
-2,020
-1,963
Net Non Operating Interest Income Expense
-3
-6
-628
-244
-139
Other Income Expense
-
-
-412
-
-63
Pretax Income
-15,482
-18,058
-10,017
-2,264
-2,165
Net Income Common Stockholders
-15,482
-18,058
-10,017
-2,264
-2,165
Diluted NI Available to Com Stockholders
-15,482
-18,058
-10,017
-2,264
-2,165
Basic EPS
-
-1.20
-0.86
-0.26
-0.15
Diluted EPS
-
-1.20
-0.86
-0.26
-0.15
Basic Average Shares
-
15,057
11,676
8,576
14,497
Diluted Average Shares
-
15,057
11,676
8,576
14,497
Total Operating Income as Reported
-15,479
-18,052
-8,977
-2,020
-1,963
Total Expenses
16,430
19,003
8,977
2,020
1,963
Net Income from Continuing & Discontinued Operation
-15,482
-18,058
-10,017
-2,264
-2,165
Normalized Income
-15,482
-18,058
-9,605
-2,264
-2,102
Interest Expense
3
6
628
244
139
Net Interest Income
-3
-6
-628
-244
-139
EBIT
-15,479
-18,052
-9,389
-2,020
-2,026
EBITDA
-15,347
-
-
-
-
Reconciled Depreciation
132
161
13
-
-
Net Income from Continuing Operation Net Minority Interest
-15,482
-18,058
-10,017
-2,264
-2,165
Total Unusual Items Excluding Goodwill
0
0
-412
0
-63
Total Unusual Items
0
0
-412
0
-63
Normalized EBITDA
-15,347
-18,052
-8,977
-2,020
-1,963
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0